Statement of Principles concerning chloracne No. 20 of 2000

Overview

The Veterans’ Entitlements Act 1986, enacted by the Australian Parliament, establishes the legislative framework governing entitlements for veterans and their families. The Act was introduced to address the need for a comprehensive and consistent system to provide benefits and support to individuals who have served in the Australian Defence Force, including the Australian Imperial Force, the Second Australian Imperial Force, and the Australian Regular Army. The Act aims to ensure that veterans receive appropriate recognition and support for any injuries, diseases, or disabilities incurred during their service. In 2000, the Repatriation Medical Authority, under subsection 196B(3) of the Veterans’ Entitlements Act 1986, issued an instrument that revoked previous statements of principles concerning chloracne and determined new principles in their place. This revision was enacted to accurately reflect the medical-scientific evidence available at the time, establishing that chloracne and death from chloracne can be related to relevant service rendered by veterans, subject to certain conditions. This update was essential to ensure that affected veterans could access the necessary support and recognition for their conditions under the Act.

Scope and Application

The Repatriation Medical Authority, under subsection 196B(3) of the Veterans’ Entitlements Act 1986, has issued a legislative instrument that revokes previous instruments and determines a new Statement of Principles concerning chloracne and death from chloracne. This instrument applies to veterans and members of the Australian Defence Force who have contracted chloracne or died from chloracne, where these conditions are linked to their service. Specifically, the instrument provides a definition of chloracne as a dermatological condition associated with exposure to halogenated organochlorine or halogenated organobromine compounds. The Authority has determined that it is more probable than not that these conditions can be related to relevant service, provided that certain factors are met, such as exposure to the specified compounds within 14 days before the onset of chloracne, or the inability to obtain appropriate clinical management for chloracne. The instrument also outlines the jurisdictional scope by applying to all matters to which section 120B of the Veterans’ Entitlements Act 1986 applies, thus ensuring that the determination is binding within the framework of the Act.

Key Provisions

The main sections of this legislation (Instrument No. 20 of 2000) involve the revocation of previous instruments (Instrument No. 70 of 1994 and Instrument No. 280 of 1995) and the establishment of a new Statement of Principles concerning chloracne and death from chloracne under section 196B(3) of the Veterans’ Entitlements Act 1986 (section 1). The new Statement of Principles defines chloracne as a dermatologic condition with cysts, comedones, and pustules appearing on specific body parts associated with exposure to halogenated organochlorine or halogenated organobromine compounds, which is coded as L70.8 in the ICD-10-AM (section 2). The Repatriation Medical Authority has determined that chloracne and death from chloracne can be related to relevant service by veterans or members of the Forces based on available medical-scientific evidence (section 3). The connection between chloracne or death from chloracne and the person’s relevant service must include exposure to halogenated compounds within 14 days before the onset of chloracne or inability to obtain appropriate clinical management for chloracne (section 5). These factors apply unless otherwise specified in the legislation (section 6). The Act imposes obligations on parties such as veterans or members of the Forces who seek to claim entitlements related to chloracne or death from chloracne. They must demonstrate that their condition is connected to relevant service by providing evidence of exposure to halogenated compounds or lack of appropriate clinical management (section 5). If the chloracne was suffered or contracted before or during relevant service but not arising out of it, then the inability to obtain appropriate clinical management can only be considered for material contribution to or aggravation of the condition (section 6). Additionally, if the condition includes an injury or disease covered by another Statement of Principles, the factors in that Statement of Principles must also be satisfied (section 7). Breach of the requirements or misrepresentation of facts in claims related to chloracne or death from chloracne can lead to various legal consequences. Under the Veterans’ Entitlements Act 1986, fraudulent claims or providing false information can result in both civil and criminal penalties. Civil penalties may include the recovery of any benefits already paid, fines, and the requirement to repay amounts received through fraudulent means. Criminal penalties can include imprisonment, with the maximum penalty varying depending on the severity and intent of the offence. These penalties are intended to deter fraudulent claims and ensure the integrity of the veterans’ entitlement system.